Role for endovascular therapy in chronic mesenteric ischemia

Area of Science:

• Vascular Surgery
• Interventional Cardiology
• Gastroenterology

Background:

• Chronic mesenteric ischemia (CMI) is a rare condition caused by mesenteric artery stenosis or occlusion, leading to abdominal pain.
• Surgical revascularization was the traditional treatment for symptomatic CMI.
• Advances in endovascular techniques offer new treatment possibilities.

Purpose of the Study:

• To discuss indications and principles of endovascular treatment for CMI.
• To review literature on endovascular treatment outcomes for CMI.
• To emphasize short- and long-term morbidity and mortality rates associated with endovascular CMI treatment.

Main Methods:

• Literature review focusing on endovascular treatment of CMI.
• Analysis of percutaneous transluminal angioplasty with stent placement outcomes.
• Evaluation of morbidity and mortality data from existing studies.

Main Results:

• Endovascular treatment, specifically angioplasty with stenting, is feasible and effective for CMI.
• This minimally invasive technique yields good long-term results with acceptable recurrence rates.
• Endovascular treatment is suggested as a primary therapeutic option for CMI.

Conclusions:

• Endovascular therapy is a viable and effective treatment for chronic mesenteric ischemia.
• Percutaneous transluminal angioplasty with stent placement provides favorable long-term outcomes.
• The review highlights the importance of endovascular approaches in managing CMI, with acceptable morbidity and mortality.